§ 44:3. Collaboration agreement between Rigel Pharmaceuticals, Inc. and Daiichi Pharmaceutical Company, Ltd. | Secondary Sources | Westlaw

§ 44:3. Collaboration agreement between Rigel Pharmaceuticals, Inc. and Daiichi Pharmaceutical Company, Ltd. | Secondary Sources | Westlaw

View on Westlaw or start a FREE TRIAL today, § 44:3. Collaboration agreement between Rigel Pharmaceuticals, Inc. and Daiichi Pharmaceutical Company, Ltd., Legal Forms
Skip Page Header

§ 44:3. Collaboration agreement between Rigel Pharmaceuticals, Inc. and Daiichi Pharmaceutical Company, Ltd.

TRANSJV § 44:3Transnational Joint VenturesSample Joint Venture Agreements (Approx. 36 pages)

§ 44:3. Collaboration agreement between Rigel Pharmaceuticals, Inc. and Daiichi Pharmaceutical Company, Ltd.

TRANSJV § 44:3Transnational Joint VenturesSample Joint Venture Agreements (Approx. 36 pages)

2 Transnational Jt Ventures § 44:3
Transnational Joint Ventures
|
September 2023 Update
Part III. Sample Joint Venture Agreements
Chapter 44. Sample Forms—Japan
§ 44:3. Collaboration agreement between Rigel Pharmaceuticals, Inc. and Daiichi Pharmaceutical Company, Ltd.
End of Document© 2024 Thomson Reuters. No claim to original U.S. Government Works.